β-thromboglobulin in urine and plasma: Influence of coronary risk factors

Thrombosis Research

Volumn 90, Issue 5, 1998, Pages 229-237

  Mundal, Håvard Holth ^a   Hjemdahl, Paul ^b   Urdal, Petter ^a   Kierulf, Peter ^a   Perneby, Christina ^b   Berg, Kåre ^a   Gjesdal, Knut ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure; Cigarette smoking; Lipoproteins; Platelet volume; thromboglobulin

Indexed keywords

BETA THROMBOGLOBULIN;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; URINALYSIS;

EID: 0032104394     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00062-0     Document Type: Article

References (33)

1. 1. Kaplan KL, Owen J. Plasma levels of platelet-secretory proteins. Crit Rev Oncol Hematol 1986;5:235-55.
2. 2. Ludlam CA. Assessment of platelet function. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Haemostasis and Thrombosis. Volume 1. New York: Churchill Livingstone; 1994. p. 199-215.
3. 3. Dawes J, Smith RC, Pepper DS. The release, distribution, and clearance of human β-thromboglobulin and platelet factor 4. Thromb Res 1978;12:851-61.
4. 4. Hjemdahl P, Perneby C, Theodorssen E, Egberg N, Larsson PT. A new assay for β-thromboglobulin in urine. Thromb Res 1991;64: 33-43.
5. 5. Bröijersén A, Hamsten A, Eriksson M, Angelin B, Hjemdahl P. Platelet activity in vivo in hyperlipoproteinemia - importance of combined hyperlipidemia. Thromb Haemost 1998;79:268-75.
6. 6. Gorgels WJMJ, Van Der Graaf Y, Hjemdahl P, Kortlandt W, Collette HJA, Erkelens WD, Banga JD. Urinary excretions of high molecular weight β-thromboglobulin and albumin are independently associated with coronary heart disease in women. Am J Epidemiol 1995;142: 1157-64.
7. 7. Mehta J, Metha P. Platelet function in hypertension and effect of therapy. Am J Cardiol 1981;47:331-4.
8. 8. Kjeldsen SE, Gjesdal K, Eide I, Aakesson I, Amundsen R, Foss OP, Leren P. Increased β-thromboglobulin in essential hypertension: Interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 1983;213:369-73.
9. 9. Lande K, Os I, Kjeldsen SE, Westheim A, Hjermann I, Gjesdal K. Increased platelet size and release reaction in essential hypertension. J Hypertens 1987;5:401-6.
10. 10. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: Comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993;22:1159-67.
11. 11. Mundal HH, Hjemdahl P, Gjesdal K. Acute effects of cigarette smoking on platelet function and plasma catecholamines in hypertensive and normotensive men. Am J Hypertens. In press 1998.
12. 12. ODES Investigators. The Oslo Diet an Exercise Study (ODES): Design and Objectives. Control Clin Trials 1993;14:229-43.
13. 13. Ludlam CA, Cash JD. Studies of the liberation of ß-thromboglobulin from human platelets in vitro. Br J Haematol 1976;33:239-47.
14. 14. Mundal HH, Nordby G, Lande K, Gjesdal K, Kjeldsen SE, Os I. Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women. Scand J Clin Lab Invest 1993;53: 585-91.
15. 15. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
16. 16. Waage H, Silsand T, Urdal P, Langård S. Discrimination of smoking status by thiocyanate and cotinine in serum, and carbon monoxide in expired air. Int J Epidemiol 1992;21:488-93.
17. 17. Rhoads GG, Dahlen G, Berg K, Morton NE, Danneberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256:2540-4.
18. 18. Falkman SE, Burrows IE, Lundgren RA, Page BFJ. A modified procedure for determination of nicotine in blood. ANALYST 1975;100: 99-104.
19. 19. Held C, Hjemdahl P, Rehnqvist N, Wallén NH, Forslund L, Bjørkander I, Angelin B, Wiman B. Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study In Stockholm (APSIS). J Intern Med 1997;241:59-69.
20. 20. Mundal HH, Gjesdal K, Landmark K. The effect of N-3 fatty acids and nifedipine on platelet function in hypertensive males. Thromb Res 1993;72:257-62.
21. 21. Anderton JL, Fananapazir L, Dawes J. Urinary β-thromboglobulin in essential hypertension. Br J Haematol 1980;44:307-11.
22. 22. Moore S, Pepper DS, Cash JD. The isolation and characterization of a platelet-specific β-globulin (β-thromboglobulin) and the detection of anti-urokinase and anti-plasmin released from thrombin-aggregated washed human platelets. Biochim Biophys Acta 1975; 379:360-9.
23. 23. Pumphrey CW, Dawes J. Plasma β-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction. Am J Cardiol 1982;50:1258-61.
24. 24. Özdemir O, Karaaslan Y, Özcebe O, Dündar S, Kirazli S. The acute effect of smoking on platelet and endothelial release reaction is suppressed in chronic smokers. Thromb Res 1992; 65:263-74.
25. 25. Cella G, Zahavi J, de Haas HA, Kakkar VV. β-thromboglobulin, platelet production time and platelet function in vascular disease. Br J Haematol 1979;43:127-36.
26. 26. Catalano M, Russo U, Belletti S, Colombo F, Belloni A, del Rosso G, Lombardi F, Libretti A. β-TG and plasma catecholamines levels after sympathetic stimuli in hypertensives and patients with peripheral disease. Thromb Haemost 1990;63:383-5.
27. 27. Ghaddar HM, Cortes J, Salomaa V, Kark JK, Davis CE, Folsom AR, Heiss G, Stinson V, Wu KK. Correlation of specific platelet activation markers with carotid arterial wall thickness. Thromb Haemost 1995;74:943-8.
28. 28. Foo LC, Roshidah I, Aimy MB. Platelets of habitual smokers have reduced susceptibility to aggregating agent. Thromb Haemost 1991; 65:317-9.
29. 29. Sharp DS, Benowitz NL, Bath PMW, Martin JF, Beswick AD, Elwood PC. Cigarette smoking sensitizes and desensitizes impedance-measured ADP-induced platelet aggregation in whole blood. Thromb Haemost 1995;74:730-5.
30. 30. Zahavi J, Betteridge JD, Jones NAG, Galton DJ, Kakkar VV. Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia. Am J Med 1981;70:59-64.
31. 31. Bröijersén A, Wallén NH, Vitols S, Larsson PT, Hjemdahl P. Autologous low density lipoprotein enhances platelet aggregation in whole blood, as measured by in vitro filtragometry. Platelets 1993;4:11-5.
32. + antiport in human platelets: A novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation 1997;95:1370-7.
33. 33. Rostrup M, Mundal HH, Kjeldsen SE, Gjesdal K, Eide I. Awareness of high blood pressure stimulates platelet release reaction. Thromb Haemostas 1990;63:367-70.